Henry Schein, Inc. (NASDAQ:HSIC) has received an average recommendation of “Hold” from the twenty ratings firms that are currently covering the company, Marketbeat Ratings reports. Two analysts have rated the stock with a sell recommendation, seven have issued a hold recommendation, nine have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year target price among analysts that have issued ratings on the stock in the last year is $86.47.
A number of brokerages have commented on HSIC. BidaskClub raised shares of Henry Schein from a “hold” rating to a “buy” rating in a research note on Wednesday, August 22nd. Cleveland Research reaffirmed a “hold” rating on shares of Henry Schein in a research note on Monday, September 24th. Zacks Investment Research raised shares of Henry Schein from a “hold” rating to a “buy” rating and set a $98.00 price target for the company in a research note on Friday, October 5th. Piper Jaffray Companies reaffirmed an “overweight” rating and set a $96.00 price target on shares of Henry Schein in a research note on Thursday, November 29th. Finally, ValuEngine raised shares of Henry Schein from a “strong sell” rating to a “sell” rating in a research note on Thursday, September 13th.
In related news, insider David Mckinley sold 8,321 shares of Henry Schein stock in a transaction dated Friday, November 30th. The shares were sold at an average price of $88.77, for a total transaction of $738,655.17. Following the completion of the sale, the insider now owns 68,012 shares in the company, valued at approximately $6,037,425.24. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO Steven Paladino sold 21,110 shares of Henry Schein stock in a transaction dated Monday, December 3rd. The shares were sold at an average price of $90.06, for a total transaction of $1,901,166.60. The disclosure for this sale can be found here. Insiders have sold a total of 98,431 shares of company stock valued at $8,595,902 in the last quarter. 1.15% of the stock is currently owned by company insiders.
Shares of NASDAQ:HSIC opened at $85.16 on Monday. Henry Schein has a 52 week low of $62.56 and a 52 week high of $91.35. The firm has a market capitalization of $12.98 billion, a price-to-earnings ratio of 23.66, a price-to-earnings-growth ratio of 2.80 and a beta of 0.89. The company has a debt-to-equity ratio of 0.29, a current ratio of 1.30 and a quick ratio of 0.70.
Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings data on Tuesday, November 6th. The company reported $1.03 EPS for the quarter, topping analysts’ consensus estimates of $1.01 by $0.02. Henry Schein had a net margin of 3.00% and a return on equity of 20.40%. The business had revenue of $3.28 billion during the quarter, compared to analysts’ expectations of $3.37 billion. During the same period last year, the company posted $0.87 EPS. The business’s revenue was up 3.8% on a year-over-year basis. As a group, research analysts expect that Henry Schein will post 4.12 EPS for the current fiscal year.
Henry Schein Company Profile
Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, animal health clinics, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Featured Article: Find a Trading Strategy That Works
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.